Crossmark

Photobiomodulation therapy with an 830-nm light-emitting diode for the prevention of thyroidectomy scars: a randomized, double-blind, sham device-controlled clinical trial

Crossref DOI link: https://doi.org/10.1007/s10103-022-03637-6

Published Online: 2022-09-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Yul Hee

Kim, Hyeung Kyoo

Choi, Jee Woong

Kim, You Chan https://orcid.org/0000-0003-4840-594X
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

Received: 22 December 2021

Accepted: 22 August 2022

First Online: 1 September 2022

Declarations

:

: The study was approved by the institutional ethics committee from Ajou University Medical Center of Suwon, Korea (AJIRB-DEV-DE2-19–445).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below